Trials / Completed
CompletedNCT02219399
DHA Supplementation and Pregnancy Outcome
Maternal DHA Supplementation and Pregnancy Outcome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 871 (actual)
- Sponsor
- Colorado State University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Supplementation with DHA during pregnancy will increase gestational length and improve cognitive development.
Detailed description
This was a trial of supplementation with DHA during pregnancy to increase gestational length. Subjects were provided with 300 mg, 600 mg or placebo (olive oil) in a randomized design from week 24-26 of pregnancy until delivery. Gestational age, birth weight and birth length data were collected and infants growth at 2 and 4 months and cognitive development at 4 months and 1 year were measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 600 mg DHA | Pregnant women were given 600 mg DHA in the last trimester of pregnancy |
| DIETARY_SUPPLEMENT | 300 mg DHA | Pregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding |
| DIETARY_SUPPLEMENT | Placebo | Pregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period |
Timeline
- Start date
- 2001-01-01
- Primary completion
- 2004-01-01
- Completion
- 2014-01-01
- First posted
- 2014-08-18
- Last updated
- 2014-08-18
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02219399. Inclusion in this directory is not an endorsement.